Pneumonia with BALF Detection of Tropheryma whipplei and Chlamydia psittaci by Targeted Next-Generation Sequencing: A Case Report Authors: Xiaoliang Li, Qi Feng Published: 2026 ABSTRACT AbstractBackgroundTropheryma whipplei (TW), a Gram-positive bacterium, is the etiologic agent of Whipple’s disease, a chronic and systemic condition that primarily involves the gastrointestinal tract. Chlamydia psittaci (C. psittaci) is a zoonotic pathogen that primarily leads to psittacosis after bird exposure. Both are fastidious organisms that are difficult to culture, and documented co-detection in pulmonary infection is relatively rare. We describe a pneumonia case in which both TW and C. psittaci were identified by targeted next-generation sequencing (tNGS).Case PresentationA 69-year-old male farmer presented with a 5-day history of high fever. After a 3-day course of oseltamivir for presumed influenza failed, he was hospitalized with persistent fever. Chest computed tomography (CT) showed patchy opacities with pleural thickening. Initial moxifloxacin therapy was ineffective. The tNGS of bronchoalveolar lavage fluid (BALF) detected TW and C. psittaci. Antibacterial therapy was switched to intravenous ceftriaxone combined with oral doxycycline. The patient’s fever subsided rapidly, inflammatory markers declined, and subsequent CT scans over six months demonstrated progressive radiographic resolution.ConclusionThis case illustrates that tNGS can provide early detection of fastidious pathogens such as TW and C. psittaci when conventional testing is unrevealing, thereby guiding targeted antimicrobial therapy and contributing to a favorable clinical outcome. A causal role for both organisms is supported by the clinical and radiographic response but would require orthogonal confirmation to be considered definitive.Keywords: Tropheryma whipplei, Chlamydia psittaci, pulmonary infection, case report, tNGS Introduction Tropheryma whipplei (TW) is an actinomycetes-associated opportunistic pathogen responsible for Whipple’s disease (WD), a rare systemic disorder predominantly affecting the gastrointestinal tract.1,2 The classic clinical manifestations of WD include a multisystemic progression featuring arthralgia, chronic diarrhea, malabsorption, and weight loss, with potential involvement of various other organ systems. Pulmonary infection caused by TW is uncommon. Chlamydia psittaci (C. psittaci) is an obligate intracellular pathogen that primarily infects humans through inhalation of organisms from infected birds, poultry, or contaminated environments.3 C. psittaci infection of humans most commonly presents in young or middle-aged adults, presenting with acute-onset fever, severe headache, and nonproductive cough. Both TW and C. psittaci are notoriously difficult to culture, complicating clinical diagnosis.1,4,5 Targeted next-generation sequencing (tNGS) facilitates rapid and precise detection of multiple pathogens in clinical specimens, thereby reducing diagnostic delays and enabling targeted therapeutic interventions.1,6,7 In this report, we describe an elderly patient with pneumonia in whom tNGS promptly identified both TW and C. psittaci, and we analyze the clinical presentation, management, and treatment outcomes. Case Presentation A 69-year-old male farmer from Chengdu, Sichuan, China presented to our hospital in March 2024 with a 5-day history of high fever (peak temperature 40°C), cough with scant yellowish sputum, chills, and diaphoresis, without hemoptysis. Two days prior to admission, he had visited another hospital during the influenza season and was empirically diagnosed with influenza, he received a 3-day course of “oral oseltamivir”, but his fever persisted between 38.5°C and 39.5°C. He was a long-term resident of Chengdu and reported no exposure to birds, poultry, or other animals. His medical history was unremarkable, with no prior hypertension, diabetes, cardiovascular events, hospitalizations, or immunodeficiency. He denied tobacco, alcohol, or drugs use. His family history was noncontributory for genetic disorders. Review of systems revealed no arthralgia, diarrhea, abdominal pain, or neurologic symptoms. On admission, vital signs included a temperature of 39.2°C, heart rate of 88 bpm, respiratory rate of 22 breaths/min, blood pressure of 129/73 mmHg, and percutaneous oxygen saturation (SpO2) of 95% while breathing ambient air. Pulmonary auscultation revealed wet rales in the right lower lobe. Chest computed tomography (CT) demonstrated scattered patchy and ground-glass opacities in the right lower lobe, with thickening of the inferior lobe interlobar septum, thickening of the right pleura, and minimal right pleural effusion (Figure 1). A routine blood examination revealed a white blood cell (WBC) count of 7.72×109/L (normal range: 3.5–9.5x109/L); the neutrophil percentage was 70.7% (normal range: 40–75%), lymphocyte percentage 23.2% (normal range: 20–50%), erythrocyte sedimentation rate (ESR) 46 mm/h (normal range: <43mm/h), and concentration of procalcitonin (PCT) 0.15 ng/mL (normal range: <0.046ng/mL). C-reactive protein (CRP) was 134.92 mg/L (normal range: <5.00mg/L). Interleukin-6 (IL-6) was 68.1pg/mL (normal range: 0.00–7.00pg/mL). Coagulation indices were: prothrombin time (PT) 12.9s (normal range: 9.6–12.8s), international normalized ratio (INR) 1.14 (normal range: 0.88–1.15), fibrinogen (Fbg) 6.35 g/L (normal range: 2–4g/L), thrombin time (TT) 15s (normal range: 14–22s), D-dimer 0.52 mg/mL FEU (normal range: <0.55 mg/mL FEU), and fibrin degradation products (FDP) < 2.5 mg/mL (normal range: <5 mg/mL). Anti-Chlamydia pneumoniae IgG was 178 AU/mL (normal range: <22.5AU/mL). Urinalysis showed mild proteinuria (0.15 g/L; normal: <0.1 g/L). Electrolytes, renal function, myocardial injury markers, tumor markers, infection markers, and mycoplasma pneumoniae testing were within normal limits. Human immunodeficiency virus testing was negative. Smear testing for acid-fast bacilli yielded a negative result. The results of all viral assays were negative, including tests for influenza A and B viruses, cytomegalovirus, Toxoplasma gondii, Epstein–Barr virus, rubella virus, and herpes simplex virus. Additionally, cryptococcal antigen testing, galactomannan assay, and β-D-glucan detection yielded negative results. The diagnostic evaluation for potential connective tissue disorders revealed no abnormalities, with negative findings for both antinuclear antibodies and rheumatoid factor. Patient’s radiological documentation before and after treatment. Chest CT scan at the patient’s initial presentation (A–C); Chest CT scan at 1 month post-treatment (D–F); Chest CT scan after 2 months of treatment (G–I); Chest CT scan after 6 months of treatment (J–L). Abbreviation: CT, computed tomography. The patient received intravenous moxifloxacin therapy (400 mg once daily) for three days. There was no clinical improvement and fever persisted up to 39.5°C. On the third day of hospitalization, the patient consented to bronchoscopy for etiological confirmation, which revealed no significant endobronchial abnormalities, shown in Figure 2. Bronchoalveolar lavage fluid (BALF) was sent for tNGS, identifying TW (sequence count: 168129) and C. psittaci (sequence count: 745572). Based on the tNGS findings and the clinical picture, a diagnosis of mixed pulmonary infection with TW and C. psittaci was made. Thus, antibiotic therapy was adjusted to intravenous ceftriaxone (2.0g on days 4–11) combined with oral doxycycline (0.2g on day 4, followed by 0.1 g bid on days 5–11). On the night of day 4 and the early morning of the day 5, the patient’s peak fever subsided, with the highest temperature reaching 37.8°C. By day 8, the laboratory test results showed a WBC total count of 5.91×109/L, neutrophil count of 3.73×109/L (62.5%), lymphocyte count of 1.67×109/L(28%), CRP 26.63 mg/L, IL-6 7.2 pg/mL and PCT 0.06 ng/mL (Table 1). During the hospitalization, no relevant pathogens were detected in sputum, bronchoalveolar lavage fluid, or blood cultures. On day 10, for convenience and to provide consolidation therapy, the regimen was transitioned to oral sulfamethoxazole-trimethoprim (SMZ-TMP, 0.48g per tablet, two tablets two times daily) and doxycycline (0.1g per tablet, one tablet two times daily), and the patient was discharged with outpatient follow‑up. One month later, a follow-up chest CT scan revealed a reduction in the size of the right lower lobe pulmonary lesion. Two months later and six months later, subsequent chest CT scans demonstrated significant absorption and reduction in the right lower lobe pulmonary lesion, shown in Figure 1. The patient remained asymptomatic during follow-up. Fiberoptic bronchoscopy of the patient. Bronchi lobaris superior dexter and bronchi lobaris medius dexter (A); right upper lobe orifices (B); right middle and lower lobe bronchial orifices (C); right lower lobe orifices (D). Table 1Laboratory Test ResultsNormal Values of Laboratory TestsDay1Day8Day33WBC (*10^9/L)3.5–9.57.725.918.28Neutrophil percentage (%)40–7570.762.534.9Lymphocyte percentage (%)20–5023.22853.6Neutrophil count (*10^9/L)1.8–6.35.463.731.84Lymphocyte count (*10^9/L)1.1–3.21.791.671.83PLT (*10^9/L)100–300211366199CRP (mg/L)< 5134.9226.63Not testedPCT (ng/mL)< 0.0460.150.06Not testedESR (mm/h)< 4346Not testedNot testedIL-6 (pg/mL)0.00–7.0068.107.20Not testedAST (U/L)0–508138Not testedALT (U/L)0–509570Not testedSerum albumin (g/L)35–553224Not testedALP (U/L)30–120234145Not testedGGT (U/L)8–57236135Not testedAbbreviations: WBC, White blood cell; PLT, Platelet; CRP, C-reactive protein; PCT, Procalcitonin; ESR, Erythrocyte sedimentation rate; IL-6, Interleukin-6; AST, Aspartate aminotransferase; ALT, Alanine aminotransferase; ALP, Alkaline phosphatase; GGT, Glutamyl transpeptidase. Laboratory Test Results Abbreviations: WBC, White blood cell; PLT, Platelet; CRP, C-reactive protein; PCT, Procalcitonin; ESR, Erythrocyte sedimentation rate; IL-6, Interleukin-6; AST, Aspartate aminotransferase; ALT, Alanine aminotransferase; ALP, Alkaline phosphatase; GGT, Glutamyl transpeptidase. Discussion Pulmonary infections caused by TW and C. psittaci exhibit nonspecific clinical and radiological features, complicating early diagnosis and management,7–9 which frequently delay diagnosis. TW is ubiquitous in the environment and is a Gram-positive bacillus related to actinomycetes. Classic WD caused by TW mainly involves the joints, gastrointestinal tract and central nervous system, while pulmonary infection is relatively rare. The radiological findings of pneumonia caused by TW are heterogeneous, including pulmonary nodules, interstitial abnormalities, patchy consolidation, and cavitary lesions.8 Compounding this challenge, the infection can occasionally progress to acute respiratory distress syndrome (ARDS) in immunocompetent hosts, a rare but severe manifestation that further obscures the clinical recognition.10 C. psittaci is an obligate intracellular gram-negative bacterium. Birds are the primary reservoir, most patients with psittacosis have a history of contact with birds. Humans are usually infected by inhalation of organisms in dried feces when caged birds exercise their wings or in bird feather dust. Psittacosis caused by C. psittaci, a zoonotic pathogen, presents with nonspecific pneumonia symptoms and atypical imaging patterns.9 Affected patients typically present with acute-onset fever and cough, often accompanied by normal leukocyte counts but marked elevations in inflammatory markers such as C-reactive protein, cardiac enzymes, and hepatic transaminases. Radiographic findings may include ground-glass opacities with consolidations and multilobar involvement, though these features are not pathognomonic for C.psittaci.11 Conventional microbiological diagnostic approaches for TW and C. psittaci infections demonstrate substantial limitations. Both pathogens are either challenging to culture or exhibit fastidious growth requirements. TW, a Gram-positive bacillus, is particularly difficult to isolate using standard culture techniques, contributing to high rates of misdiagnosis.7 C. psittaci, as an obligate intracellular pathogen, cannot be effectively cultured using conventional media.12 Traditional culture-based detection methods (CMTs) demonstrate significantly low sensitivity for both pathogens.6 Traditional diagnostic approaches such as serological antibody assays are susceptible to cross-reactivity artifacts and may be compromised by immunological window periods.13 While polymerase chain reaction (PCR) based methodologies exhibit superior sensitivity compared to culture techniques, they necessitate a priori specification of target pathogens and consequently fail to identify unexpected or rare microbial species.13 These diagnostic constraints collectively contribute to the substantial underdiagnosis of pulmonary infections caused by TW and C. psittaci in clinical settings. The tNGS technology substantially improves pathogen detection efficiency through the selective amplification of specific genomic regions followed by high-throughput sequencing, particularly for rare and atypical pathogens that are challenging to identify using conventional diagnostic methods. It achieves diagnostic performance comparable to metagenomic next-generation sequencing (mNGS) for lower respiratory tract infections while offering faster turnaround (typically 24–48 hours) and lower cost.14–16In this case, tNGS provided an etiologic diagnosis within 24 hours and detected both TW and C. psittaci from BALF at high sequence counts, enabling timely targeted therapy. The very high read numbers for both organisms, together with the patient’s failure of moxifloxacin monotherapy and the rapid clinical and radiographic improvement after the addition of ceftriaxone and doxycycline, suggest that both TW and C. psittaci contributed to the pneumonia. However, it is important to acknowledge that tNGS detection alone does not definitively distinguish active infection from colonization or incidental signal; no confirmatory orthogonal test such as species-specific PCR or immunohistochemistry was available in this case. Therefore, although the therapeutic response to a regimen active against both organisms provides supportive clinical evidence, the lack of independent validation by PCR or culture is also a limitation of this report. Reports of co-infection with TW and C. psittaci remain scarce. No universally standardized therapeutic regimen currently exists. In vitro susceptibility testing of TW using cell culture and real-time polymerase chain reaction assays has demonstrated activity for multiple antibiotic classes, including doxycycline, cephalosporins, macrolides, and TMP-SMX. However, the optimal clinical regimen remains uncertain.17 A clinical trial in WD demonstrated high remission rates with a 14-day induction with either ceftriaxone or meropenem, followed by oral TMP-SMX.18 For psittacosis, tetracyclines, particularly doxycycline, are the agents of choice, and most patients defervesce within 48 hours.19,20 Because the patient remained febrile on moxifloxacin alone, based on clinical experience and guidelines, treatment for TW and C. psittaci detected by tNGS was switched to ceftriaxone plus doxycycline to cover both organisms. The rapid defervescence and normalization of inflammatory markers support the appropriateness of this regimen. On day 10, the regimen was transitioned to oral TMP-SMX plus doxycycline as consolidation, taking into account patient convenience for WD maintenance therapy. Follow-up imaging showed marked improvement in the pulmonary infiltrates. This report has limitations. First, although tNGS identified both TW and C. psittaci, due to the clinical urgency and the fastidious nature of the organisms, orthogonal validation by PCR or culture was not performed. Second, the absence of tissue biopsy precludes definitive confirmation of invasive infection. Third, the generalizability of the findings is limited to a single case. Despite these limitations, the case illustrates the clinical utility of tNGS in managing severe, culture‑negative pneumonia and emphasizes the need for further research into polymicrobial infections involving fastidious pathogens. Conclusion Pulmonary infections caused by TW and C. psittaci pose considerable diagnostic challenges owing to their nonspecific clinical presentations and the limitations of conventional diagnostic techniques. The tNGS technology, characterized by high sensitivity, broad genomic coverage, rapid turnaround time, and the ability to detect antimicrobial resistance genes, has significantly enhanced the detection rates of these uncommon pathogens. In this case, detection of both organisms by tNGS, together with a prompt clinical response, supports a diagnosis of co-infection, although orthogonal confirmation is desirable. The case highlights the value of incorporating advanced molecular diagnostics into the workup of severe, unexplained pneumonia. Acknowledgments We thank all the medical professionals who treated this patient. Funding Statement The authors declare that no financial support was received for the research, authorship, and/or publication of this article. Data Sharing Statement The original contributions presented in the study are included in the article material. Further inquiries can be directed to the corresponding author. Ethics approval and consent to participate This study was approved by the Institutional Review Board of West China Tianfu Hospital, Sichuan University. Consent for Publication Informed written consent was obtained from the patient for publication of this report and any accompanying images. Author Contributions All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work. Disclosure The authors state that they have no conflicts of interest in this work. References Associated Data Data Availability Statement The original contributions presented in the study are included in the article material. Further inquiries can be directed to the corresponding author.